These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 20695081)

  • 1. Fluconazole susceptibility and genotypic heterogeneity of oral Candida albicans colonies from the patients with cancer receiving chemotherapy in China.
    Sun J; Qi C; Lafleur MD; Qi QG
    Int J Oral Sci; 2009 Sep; 1(3):156-62. PubMed ID: 20695081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular heterogeneity of fluconazole-resistant and -susceptible oral Candida albicans isolates within a single geographic locale.
    Dassanayake RS; Ellepola AN; Samaranayake YH; Samaranayak LP
    APMIS; 2002 Apr; 110(4):315-24. PubMed ID: 12076267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Replacement of Candida albicans with C. dubliniensis in human immunodeficiency virus-infected patients with oropharyngeal candidiasis treated with fluconazole.
    Martinez M; López-Ribot JL; Kirkpatrick WR; Coco BJ; Bachmann SP; Patterson TF
    J Clin Microbiol; 2002 Sep; 40(9):3135-9. PubMed ID: 12202543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VT-1161 protects mice against oropharyngeal candidiasis caused by fluconazole-susceptible and -resistant Candida albicans.
    Break TJ; Desai JV; Natarajan M; Ferre EMN; Henderson C; Zelazny AM; Siebenlist U; Hoekstra WJ; Schotzinger RJ; Garvey EP; Lionakis MS
    J Antimicrob Chemother; 2018 Jan; 73(1):151-155. PubMed ID: 29040636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iranian HIV/AIDS patients with oropharyngeal candidiasis: identification, prevalence and antifungal susceptibility of Candida species.
    Khedri S; Santos ALS; Roudbary M; Hadighi R; Falahati M; Farahyar S; Khoshmirsafa M; Kalantari S
    Lett Appl Microbiol; 2018 Oct; 67(4):392-399. PubMed ID: 30019443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [25S rDNA genotype and antifungal susceptibility of vaginal Candida albicans].
    Zhang X; Liu ZH
    Zhonghua Fu Chan Ke Za Zhi; 2016 Apr; 51(4):279-84. PubMed ID: 27116986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microbiological screening of Irish patients with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy reveals persistence of Candida albicans strains, gradual reduction in susceptibility to azoles, and incidences of clinical signs of oral candidiasis without culture evidence.
    McManus BA; McGovern E; Moran GP; Healy CM; Nunn J; Fleming P; Costigan C; Sullivan DJ; Coleman DC
    J Clin Microbiol; 2011 May; 49(5):1879-89. PubMed ID: 21367996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular typing and in vitro fluconazole susceptibility of Candida species isolated from diabetic and nondiabetic women with vulvovaginal candidiasis in India.
    Lattif AA; Mukhopadhyay G; Banerjee U; Goswami R; Prasad R
    J Microbiol Immunol Infect; 2011 Jun; 44(3):166-71. PubMed ID: 21524609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variations in fluconazole susceptibility and DNA subtyping of multiple Candida albicans colonies from patients with AIDS and oral candidiasis suffering one or more episodes of infection.
    Redding SW; Pfaller MA; Messer SA; Smith JA; Prows J; Bradley LL; Fothergill AW; Rinaldi MG
    J Clin Microbiol; 1997 Jul; 35(7):1761-5. PubMed ID: 9196188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Susceptibility of yeasts to antifungal agents in Kaunas University of Medicine Hospital].
    Skrodeniene E; Dambrauskiene A; Vitkauskiene A
    Medicina (Kaunas); 2006; 42(4):294-9. PubMed ID: 16687901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro susceptibility of Candida albicans clinical isolates to eight antifungal agents in Ouagadougou (Burkina Faso).
    Zida A; Yacouba A; Bamba S; Sangare I; Sawadogo M; Guiguemde T; Kone S; Traore LK; Ouedraogo-Traore R; Guiguemde RT
    J Mycol Med; 2017 Dec; 27(4):469-475. PubMed ID: 28754462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation, speciation and antifungal susceptibility testing of Candida isolates from various clinical specimens at a tertiary care hospital, Nepal.
    Khadka S; Sherchand JB; Pokhrel BM; Parajuli K; Mishra SK; Sharma S; Shah N; Kattel HP; Dhital S; Khatiwada S; Parajuli N; Pradhan M; Rijal BP
    BMC Res Notes; 2017 Jun; 10(1):218. PubMed ID: 28646915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of oropharyngeal Candida colonization and infection in patients receiving radiation for head and neck cancer.
    Redding SW; Zellars RC; Kirkpatrick WR; McAtee RK; Caceres MA; Fothergill AW; Lopez-Ribot JL; Bailey CW; Rinaldi MG; Patterson TF
    J Clin Microbiol; 1999 Dec; 37(12):3896-900. PubMed ID: 10565903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular epidemiology of Candida albicans strains isolated from the oropharynx of HIV-positive patients at successive clinic visits.
    Lasker BA; Elie CM; Lott TJ; Espinel-Ingroff A; Gallagher L; Kuykendall RJ; Kellum ME; Pruitt WR; Warnock DW; Rimland D; McNeil MM; Reiss E
    Med Mycol; 2001 Aug; 39(4):341-52. PubMed ID: 11556764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oropharyngeal candidiasis in head and neck cancer patients in Iran: Species identification, antifungal susceptibility and pathogenic characterization.
    Jahanshiri Z; Manifar S; Moosa H; Asghari-Paskiabi F; Mahmoodzadeh H; Shams-Ghahfarokhi M; Razzaghi-Abyaneh M
    J Mycol Med; 2018 Jun; 28(2):361-366. PubMed ID: 29602636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular and phenotypic characterization of genotypic Candida albicans subgroups and comparison with Candida dubliniensis and Candida stellatoidea.
    McCullough MJ; Clemons KV; Stevens DA
    J Clin Microbiol; 1999 Feb; 37(2):417-21. PubMed ID: 9889231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Molecular epidemiologic surveillance and antifungal agent sensitivity of Candida albicans isolated from anesthesia intensive care units].
    Gülay Z; Ergon C; Ozkütük A; Yücesoy M; Biçmen M
    Mikrobiyol Bul; 2002; 36(3-4):309-16. PubMed ID: 12838665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneity in antifungal susceptibility of clones of Candida albicans isolated on single and sequential visits from a HIV-infected southern Chinese cohort.
    Samaranayake YH; Samaranayake LP; Tsang PC; Wong KH; Yeung KW
    J Oral Pathol Med; 2001 Jul; 30(6):336-46. PubMed ID: 11459319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variation in random amplified polymorphic DNA (RAPD) profiles specific to fluconazole-resistant and -sensitive strains of Candida albicans.
    Jain P; Khan ZK; Bhattacharya E; Ranade SA
    Diagn Microbiol Infect Dis; 2001 Nov; 41(3):113-9. PubMed ID: 11750163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and susceptibility testing of oral candidiasis in advanced cancer patients.
    Monsen RE; Kristoffersen AK; Gay CL; Herlofson BB; Fjeld KG; Hove LH; Nordgarden H; Tollisen A; Lerdal A; Enersen M
    BMC Oral Health; 2023 Apr; 23(1):223. PubMed ID: 37072843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.